|
US5239084A
(en)
|
1990-06-29 |
1993-08-24 |
Hoffmann-La Roche Inc. |
Substituted aminoalkyl biphenyl compounds
|
|
US5827868A
(en)
|
1991-10-07 |
1998-10-27 |
E. R. Squibb & Sons, Inc. |
Prostaglandin analogs
|
|
US5565485A
(en)
|
1993-03-19 |
1996-10-15 |
Merck & Co., Inc. |
Biphenyl compounds useful or endothelin antagonists
|
|
US5334598A
(en)
|
1993-03-19 |
1994-08-02 |
Merck & Co., Inc. |
Six-membered ring fused imidazoles substituted with phenoxyphenylacetic acid derivatives
|
|
US5391566A
(en)
|
1993-07-20 |
1995-02-21 |
Merck & Co., Inc. |
Benzimidazolinones substituted with phenoxyphenylacetic acid derivatives
|
|
DE19601782A1
(de)
|
1996-01-19 |
1997-07-24 |
Merck Patent Gmbh |
Chinolin-2-(1H)one
|
|
CO4960662A1
(es)
*
|
1997-08-28 |
2000-09-25 |
Novartis Ag |
Ciertos acidos 5-alquil-2-arilaminofenilaceticos y sus derivados
|
|
AU4692399A
(en)
|
1998-06-17 |
2000-01-05 |
Du Pont Pharmaceuticals Company |
Cyclic hydroxamic acids as metalloproteinase inhibitors
|
|
US6617351B1
(en)
|
1998-07-31 |
2003-09-09 |
Eli Lilly And Company |
Amide, carbamate, and urea derivatives
|
|
EP1177176B1
(en)
|
1999-04-28 |
2006-04-19 |
Aventis Pharma Deutschland GmbH |
Tri-aryl acid derivatives as ppar receptor ligands
|
|
DE19937537A1
(de)
|
1999-08-09 |
2001-03-08 |
Gruenenthal Gmbh |
Substituierte 2-Dialkylaminoalkylbiphenyl-Derivate
|
|
JP3486408B2
(ja)
|
1999-08-23 |
2004-01-13 |
株式会社ビー・エム・エル |
物質のヒトプロスタグランジンｄ２受容体に対する性質の同定方法
|
|
US20010047027A1
(en)
|
2000-04-12 |
2001-11-29 |
Marc Labelle |
Prostaglandin D2 receptor antagonists
|
|
US6878522B2
(en)
|
2000-07-07 |
2005-04-12 |
Baiyong Li |
Methods for the identification of compounds useful for the treatment of disease states mediated by prostaglandin D2
|
|
JP4279561B2
(ja)
|
2001-05-23 |
2009-06-17 |
メルク フロスト カナダ リミテツド |
プロスタグランジンＤ２受容体拮抗薬としてのジヒドロピロロ［１，２−ａ］インドールおよびテトラヒドロピリド［１，２−ａ］−インドール誘導体
|
|
US20030114457A1
(en)
|
2001-07-09 |
2003-06-19 |
Axys Pharmaceuticals, Inc. |
2- [5- (5-carbamimidoyl-1H-heteroaryl)-6-hydroxybiphenyl-3-yl]-succinic acid derivatives as factor viia inhibitors
|
|
EP1435946B8
(en)
*
|
2001-09-14 |
2013-12-18 |
Amgen Inc. |
Linked biaryl compounds
|
|
EP1558614B1
(en)
|
2002-10-30 |
2010-09-01 |
Merck Frosst Canada Ltd. |
Pyridopyrrolizine and pyridoindolizine derivatives
|
|
JP2004182657A
(ja)
|
2002-12-04 |
2004-07-02 |
Eisai Co Ltd |
Ｈｄｌレベル上昇促進剤
|
|
ZA200505523B
(en)
|
2002-12-20 |
2006-09-27 |
Amgen Inc |
Asthma and allergic inflammation modulators
|
|
DE60303238T2
(de)
|
2003-04-25 |
2006-09-14 |
Actimis Pharmaceuticals, Inc., La Jolla |
Pyrimidin-Essigsäure Derivate geeignet zur Behandlung von CRTH2-bedingten Krankheiten
|
|
AU2004283139A1
(en)
|
2003-10-14 |
2005-05-06 |
Oxagen Limited |
Compounds having CRTH2 antagonist activity
|
|
GB0324763D0
(en)
|
2003-10-23 |
2003-11-26 |
Oxagen Ltd |
Use of compounds in therapy
|
|
CA2547430A1
(en)
|
2003-11-26 |
2005-06-09 |
Takeda Pharmaceutical Company Limited |
Receptor function regulating agent
|
|
US7019022B2
(en)
|
2003-12-15 |
2006-03-28 |
Merck Frosst Canada & Co. |
Substituted tetrahydrocarbazole and cyclopentanoindole derivatives
|
|
CN1942428A
(zh)
|
2004-04-13 |
2007-04-04 |
默克公司 |
Cetp抑制剂
|
|
GB0409921D0
(en)
|
2004-05-04 |
2004-06-09 |
Novartis Ag |
Organic compounds
|
|
GB0415320D0
(en)
|
2004-07-08 |
2004-08-11 |
Astrazeneca Ab |
Novel compounds
|
|
MX2007001943A
(es)
|
2004-08-17 |
2007-05-09 |
Galderma Res & Dev |
Nuevos compuestos biaromaticos activadores de los receptores del tipo receptor activado del proliferador de peroxisoma (ppar) y su uso en composiciones cosmeticas o farmaceuticas.
|
|
AU2005286717A1
(en)
|
2004-09-21 |
2006-03-30 |
Wyeth |
Benzimidazole acetic acids exhibiting CRTH2 receptor antagonism and uses thereof
|
|
MX2007003336A
(es)
|
2004-09-21 |
2007-06-05 |
Athersys Inc |
Acidos aceticos de indol que muestran antagonismo de receptor crth2 y usos de los mismos.
|
|
US20070299122A1
(en)
|
2004-11-08 |
2007-12-27 |
Tobert Jonathan A |
Method of Treating Pathological Blushing
|
|
PE20061124A1
(es)
|
2004-11-23 |
2006-10-13 |
Pfizer Prod Inc |
Compuestos y derivados de dibencil amina
|
|
GB0510584D0
(en)
|
2005-05-24 |
2005-06-29 |
Novartis Ag |
Organic compounds
|
|
GB0518783D0
(en)
|
2005-09-14 |
2005-10-26 |
Argenta Discovery Ltd |
Indolizine compounds
|
|
AU2006296004B2
(en)
|
2005-09-27 |
2011-11-17 |
Shionogi & Co., Ltd. |
Sulfonamide derivative having PGD2 receptor antagonistic activity
|
|
US8148572B2
(en)
|
2005-10-06 |
2012-04-03 |
Astrazeneca Ab |
Compounds
|
|
ATE545637T1
(de)
*
|
2005-12-15 |
2012-03-15 |
Astrazeneca Ab |
Substituierte diphenylether, -amine, -sulfide und methane zur behandlung von atemwegserkrankungen
|
|
WO2007079078A1
(en)
|
2005-12-29 |
2007-07-12 |
Bayer Schering Pharma Aktiengesellschaft |
Diamine derivatives as inhibitors of leukotriene a4 hydrolase
|
|
BRPI0712332A2
(pt)
*
|
2006-06-09 |
2012-12-18 |
Icos Corp |
composto e derivados farmaceuticamente aceitáveis dos mesmos, composição farmacêutica, método de antagonização de um receptor dp-2, e, uso de um composto
|
|
MY149934A
(en)
*
|
2006-08-21 |
2013-10-31 |
Array Biopharma Inc |
4-substituted phenoxyphenylacetic acid derivatives
|
|
JP5539864B2
(ja)
|
2007-06-12 |
2014-07-02 |
アカオゲン，インコーポレーテッド |
抗菌剤
|
|
CN101687844B
(zh)
|
2007-07-02 |
2013-11-13 |
弗·哈夫曼-拉罗切有限公司 |
用作ccr2受体拮抗剂的咪唑衍生物
|
|
CN101801952A
(zh)
|
2007-10-01 |
2010-08-11 |
弗·哈夫曼-拉罗切有限公司 |
用作ccr受体拮抗剂的n-杂环联芳基甲酰胺类化合物
|
|
GB0719521D0
(en)
|
2007-10-05 |
2007-11-14 |
Argenta Discovery Ltd |
Compounds
|
|
GB0722203D0
(en)
|
2007-11-13 |
2007-12-19 |
Oxagen Ltd |
Use of CRTH2 antagonist compounds
|
|
GB0722216D0
(en)
|
2007-11-13 |
2007-12-27 |
Oxagen Ltd |
Use of crth2 antagonist compounds
|
|
AU2009204700B2
(en)
|
2008-01-18 |
2013-07-04 |
Atopix Therapeutics Limited |
Compounds having CRTH2 antagonist activity
|
|
CN101952244B
(zh)
|
2008-02-01 |
2014-11-05 |
潘米拉制药公司 |
前列腺素d2受体的n，n-二取代氨基烷基联苯拮抗剂
|
|
UA98839C2
(en)
|
2008-02-01 |
2012-06-25 |
Панмира Фармасьютикалз, Ллк. |
N,n-disubstituted aminoalkylbiphenyl antagonists of prostaglandin d2 receptors
|
|
EP2257536A4
(en)
|
2008-02-14 |
2011-03-23 |
Amira Pharmaceuticals Inc |
CYCLIC DIARYL ETHERS AS ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS
|
|
WO2009145989A2
(en)
*
|
2008-04-02 |
2009-12-03 |
Amira Pharmaceuticals, Inc. |
Aminoalkylphenyl antagonists of prostaglandin d2 receptors
|
|
EP2307362A4
(en)
|
2008-07-03 |
2012-05-09 |
Panmira Pharmaceuticals Llc |
ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS
|
|
WO2010039977A2
(en)
|
2008-10-01 |
2010-04-08 |
Amira Pharmaceuticals, Inc. |
Heteroaryl antagonists of prostaglandin d2 receptors
|
|
US8524748B2
(en)
|
2008-10-08 |
2013-09-03 |
Panmira Pharmaceuticals, Llc |
Heteroalkyl biphenyl antagonists of prostaglandin D2 receptors
|
|
US8383654B2
(en)
|
2008-11-17 |
2013-02-26 |
Panmira Pharmaceuticals, Llc |
Heterocyclic antagonists of prostaglandin D2 receptors
|
|
US20100173313A1
(en)
|
2009-01-08 |
2010-07-08 |
Amira Pharmaceuticals, Inc. |
Biomarkers of inflammation
|
|
CN102596193A
(zh)
|
2009-07-31 |
2012-07-18 |
潘米拉制药公司 |
Dp2受体拮抗的皮肤调配物
|
|
KR20120038544A
(ko)
*
|
2009-07-31 |
2012-04-23 |
판미라 파마슈티칼스, 엘엘씨 |
Ｄｐ2 수용체 길항제의 안과용 약학 조성물
|